Psoriasis and Papulosquamous Disorders.
Where this comes from
- Record sourced from PubMed, PMID 40835291.
- Also identified by DOI 10.1016/j.pop.2025.05.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Psoriasis is a chronic, inflammatory skin disease with a significant impact on quality of life. Psoriasis affects about 3% of the US population. Psoriasis is caused by an interaction between genetic and environmental triggers. Lifestyle modification and topical therapies such as emollients, topical corticosteroids, vitamin D analogues, and calcineurin inhibitors are used for limited disease. More severe psoriasis may require systemic therapy with available oral or biologic therapy.
Medical subject headings
- Psoriasis